← Back to Search

Best Practice Alert (BPA) for Heart Failure (BETTER CARE-HF Trial)

N/A
Waitlist Available
Led By Amrita Mukhopadhyay, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, 1 year
Awards & highlights

BETTER CARE-HF Trial Summary

This trial will compare the effectiveness of two targeted clinical decision support intervention tools (best practice alert and automated in-basket massage) to inform providers when a patient with heart failure and reduce ejection fraction is not on appropriate medical therapy, as compared to usual care.

Eligible Conditions
  • Heart Failure

BETTER CARE-HF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of patients prescribed MRA
Secondary outcome measures
Incidence of provider engagement with each alert type

BETTER CARE-HF Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: In-Basket Message groupExperimental Treatment1 Intervention
Providers will receive a monthly in-basket messages linking to a list of patients who have been seen in the past 2 months or will be seen in the upcoming month with HFrEF who are not on MRA (and who do not have contraindication to MRA). This list will display each patient's current hFrEF therapies, EF, blood pressure, potassium, glomerular filtration rate, date of last visit, and date of next visit. From the list, providers can access the patient's chart, order medications, and document communication with the patient.
Group II: Best Practice Alert groupExperimental Treatment1 Intervention
Providers will receive a BPA at the time of visit for patients with HFrEF who are not on MRA (and who do not have contraindication to MRA). This alert will display the patient's current HFrEF therapies, EF, blood pressure, potassium, and glomerular filtration rate. The alert will give access to an outpatient heart failure order set, and also provide links to the most recent guidelines.
Group III: Control groupActive Control1 Intervention
Patients who will receive the current standard practice of care (no BPA or in-basket message)

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
837,515 Total Patients Enrolled
15 Trials studying Heart Failure
10,767 Patients Enrolled for Heart Failure
Amrita Mukhopadhyay, MDPrincipal InvestigatorNYU Langone Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF)
2022. "Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05275920.
~758 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top